|
|
|
91.8% |
|
|
|
91.8% |
|
|
|
91.5% |
|
|
|
91.3% |
|
|
|
91.1% |
|
|
|
90.4% |
|
|
|
86.9% |
|
|
|
85.7% |
|
|
|
84.8% |
|
|
|
82.2% |
|
|
|
82.0% |
|
|
|
81.9% |
|
|
|
81.1% |
|
|
|
81.1% |
|
|
|
81.0% |
|
|
|
79.8% |
|
|
|
79.2% |
|
|
|
78.6% |
|
|
|
78.6% |
|
|
|
75.0% |
|
|
|
72.7% |
|
|
|
62.0% |
|
|
|
44.3% |
|
|
|
18.9% |
Maexxna
|
|
2.6% |